FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808757367> ?p ?o ?g. }

• W2808757367 endingPage "3342" @default.
• W2808757367 startingPage "3332" @default.
• W2808757367 abstract "The assessment of drug-polymer equilibrium solubility is of critical importance for predicting suitable loading and physical stability of solid dispersion formulations. However, quantitative measurement of this parameter is nontrivial due to the difficulties associated with ascertaining equilibrium values in systems that are prone to supersaturation and are simultaneously highly viscous, thereby slowing the equilibration process considerably; no standard methodology has yet been agreed for such measurements. In this study, we propose a new approach involving quasi-isothermal modulated temperature DSC (QiMTDSC), whereby unsaturated and supersaturated samples are held at defined temperatures and subject to a sinusoidal heating signal at a zero underpinning heating rate, thereby allowing the heat capacity of the sample to be measured as a function of time and temperature. We are not only able to ascertain whether equilibrium has been reached by monitoring the time-dependent heat capacity signal, but we can also measure solubility as a function of temperature via the absolute heat capacity values of the components. We are also able to measure the kinetics of recrystallization from the supersaturated systems. Dispersions of olanzapine in PLGA at concentrations up to 50% w/w, prepared by spray drying, were prepared and characterized using conventional and QiMTDSC as well as hot stage microscopy. The new QiMTDSC protocol was successfully able to determine olanzapine solubility in PLGA at 90 °C to be 23.1 ± 6.1% w/w, which was comparable to the values calculated using other established methods at this temperature, while a temperature/solubility profile was obtained using the method at a range of temperatures. Drug crystallization kinetics from the solid dispersions could also be modeled directly from the QiMTDSC data using the Avrami approach, thereby allowing the effect of drug loading on the rate of crystallization and the effective completion of crystallization to be investigated. Overall, an alternative protocol for measuring drug-polymer solubility has been developed and validated via comparison to established methods, the approach allowing solubility as a function of temperature, identification of equilibrium following demixing, and kinetic analysis of crystallization to be performed within one set of experiments." @default.
• W2808757367 created "2018-06-29" @default.
• W2808757367 creator A5013181090 @default.
• W2808757367 creator A5026797774 @default.
• W2808757367 creator A5035093559 @default.
• W2808757367 creator A5045425376 @default.
• W2808757367 creator A5063675922 @default.
• W2808757367 date "2018-06-22" @default.
• W2808757367 modified "2023-09-25" @default.
• W2808757367 title "The Development of Quasi-isothermal Calorimetry for the Measurement of Drug–Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles" @default.
• W2808757367 cites W1014687656 @default.
• W2808757367 cites W1965426077 @default.
• W2808757367 cites W1968370225 @default.
• W2808757367 cites W1985071287 @default.
• W2808757367 cites W1988652094 @default.
• W2808757367 cites W1989794259 @default.
• W2808757367 cites W1989801989 @default.
• W2808757367 cites W1990906132 @default.
• W2808757367 cites W1991875921 @default.
• W2808757367 cites W1993507577 @default.
• W2808757367 cites W2016152469 @default.
• W2808757367 cites W2024908520 @default.
• W2808757367 cites W2026425017 @default.
• W2808757367 cites W2030868464 @default.
• W2808757367 cites W2044146593 @default.
• W2808757367 cites W2047948690 @default.
• W2808757367 cites W2048016595 @default.
• W2808757367 cites W2056434768 @default.
• W2808757367 cites W2056491432 @default.
• W2808757367 cites W2066120836 @default.
• W2808757367 cites W2074176923 @default.
• W2808757367 cites W2085966579 @default.
• W2808757367 cites W2087242525 @default.
• W2808757367 cites W2087493711 @default.
• W2808757367 cites W2094506063 @default.
• W2808757367 cites W2112452884 @default.
• W2808757367 cites W2133822606 @default.
• W2808757367 cites W2157408003 @default.
• W2808757367 cites W2157532054 @default.
• W2808757367 cites W2160056824 @default.
• W2808757367 cites W2160333246 @default.
• W2808757367 cites W2161059539 @default.
• W2808757367 cites W2190949340 @default.
• W2808757367 cites W2320892052 @default.
• W2808757367 cites W2326044312 @default.
• W2808757367 cites W2588546100 @default.
• W2808757367 cites W2792918702 @default.
• W2808757367 doi "https://doi.org/10.1021/acs.molpharmaceut.8b00364" @default.
• W2808757367 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29933697" @default.
• W2808757367 hasPublicationYear "2018" @default.
• W2808757367 type Work @default.
• W2808757367 sameAs 2808757367 @default.
• W2808757367 citedByCount "7" @default.
• W2808757367 countsByYear W28087573672019 @default.
• W2808757367 countsByYear W28087573672020 @default.
• W2808757367 countsByYear W28087573672021 @default.
• W2808757367 countsByYear W28087573672023 @default.
• W2808757367 crossrefType "journal-article" @default.
• W2808757367 hasAuthorship W2808757367A5013181090 @default.
• W2808757367 hasAuthorship W2808757367A5026797774 @default.
• W2808757367 hasAuthorship W2808757367A5035093559 @default.
• W2808757367 hasAuthorship W2808757367A5045425376 @default.
• W2808757367 hasAuthorship W2808757367A5063675922 @default.
• W2808757367 hasBestOaLocation W28087573671 @default.
• W2808757367 hasConcept C100293340 @default.
• W2808757367 hasConcept C110884469 @default.
• W2808757367 hasConcept C113196181 @default.
• W2808757367 hasConcept C121332964 @default.
• W2808757367 hasConcept C133347239 @default.
• W2808757367 hasConcept C147789679 @default.
• W2808757367 hasConcept C148898269 @default.
• W2808757367 hasConcept C155574463 @default.
• W2808757367 hasConcept C178790620 @default.
• W2808757367 hasConcept C185592680 @default.
• W2808757367 hasConcept C192562407 @default.
• W2808757367 hasConcept C200447597 @default.
• W2808757367 hasConcept C202270520 @default.
• W2808757367 hasConcept C203036418 @default.
• W2808757367 hasConcept C43617362 @default.
• W2808757367 hasConcept C521977710 @default.
• W2808757367 hasConcept C60205243 @default.
• W2808757367 hasConcept C62520636 @default.
• W2808757367 hasConcept C97355855 @default.
• W2808757367 hasConceptScore W2808757367C100293340 @default.
• W2808757367 hasConceptScore W2808757367C110884469 @default.
• W2808757367 hasConceptScore W2808757367C113196181 @default.
• W2808757367 hasConceptScore W2808757367C121332964 @default.
• W2808757367 hasConceptScore W2808757367C133347239 @default.
• W2808757367 hasConceptScore W2808757367C147789679 @default.
• W2808757367 hasConceptScore W2808757367C148898269 @default.
• W2808757367 hasConceptScore W2808757367C155574463 @default.
• W2808757367 hasConceptScore W2808757367C178790620 @default.
• W2808757367 hasConceptScore W2808757367C185592680 @default.
• W2808757367 hasConceptScore W2808757367C192562407 @default.
• W2808757367 hasConceptScore W2808757367C200447597 @default.
• W2808757367 hasConceptScore W2808757367C202270520 @default.
• W2808757367 hasConceptScore W2808757367C203036418 @default.
• W2808757367 hasConceptScore W2808757367C43617362 @default.

• next